Compare PMTS & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PMTS | STXS |
|---|---|---|
| Founded | 2007 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 192.1M | 183.7M |
| IPO Year | 2015 | 2004 |
| Metric | PMTS | STXS |
|---|---|---|
| Price | $20.96 | $1.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $27.67 | $4.00 |
| AVG Volume (30 Days) | 47.8K | ★ 489.4K |
| Earning Date | 05-05-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.67 |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $312,189,000.00 | $29,346,617.00 |
| Revenue This Year | $9.95 | $28.22 |
| Revenue Next Year | $10.02 | $30.47 |
| P/E Ratio | $122.18 | ★ N/A |
| Revenue Growth | ★ 12.27 | N/A |
| 52 Week Low | $10.81 | $1.59 |
| 52 Week High | $21.73 | $3.59 |
| Indicator | PMTS | STXS |
|---|---|---|
| Relative Strength Index (RSI) | 65.07 | 48.72 |
| Support Level | $16.67 | $1.74 |
| Resistance Level | N/A | $1.99 |
| Average True Range (ATR) | 0.91 | 0.10 |
| MACD | 0.17 | 0.00 |
| Stochastic Oscillator | 78.27 | 50.00 |
CPI Card Group Inc is a payment technology company engaged in providing financial payment card solutions and services. It offers credit, debit, and prepaid cards. The business segments of the group are Debit and Credit segment, which principally produce secure debit and credit cards and provide card services for U.S. card-issuing financial institutions, including personalization, instant issuance and other payment solutions such as digital push provisioning for mobile wallets; Prepaid Debit, which provides secure packaging solutions, Prepaid Debit Cards, and other integrated prepaid card services to prepaid program managers in the U.S.; and other: principally corporate expenses. The firm generates key revenue from Debit and Credit segment.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.